What were the most common adverse reactions to Zerbaxa in adult trials of complicated intra-abdominal and urinary tract infections?

The most common adverse reactions to Zerbaxa in pooled adult Phase 3 trials of complicated intra-abdominal and complicated urinary tract infections (including pyelonephritis) were nausea, headache, constipation, diarrhoea and pyrexia, each occurring in ≥3% of patients and generally mild or moderate in severity.